(Q37912800)

25 August 2017

title

Neurological complications and behavioral problems in patients with phenylketonuria in a follow-up unit (English)

1 reference

25 August 2017

1 reference

María J González

1

1 reference

25 August 2017

Alfonso P Gutiérrez

2

1 reference

25 August 2017

Rosa Gassió

3

1 reference

25 August 2017

María E Fusté

4

1 reference

25 August 2017

María A Vilaseca

5

1 reference

25 August 2017

Jaume Campistol

6

1 reference

25 August 2017

publication date

23 July 2011

1 reference

Molecular Genetics and Metabolism

25 August 2017

published in

1 reference

25 August 2017

volume

104 Suppl

1 reference

25 August 2017

page(s)

S73-9

1 reference

Nutrition, physical growth, and bone density in treated phenylketonuria

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Phenylketonuria: dietary and therapeutic challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Intelligence and quality of dietary treatment in phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Deficits in selective and sustained attention processes in early treated children with phenylketonuria--result of impaired frontal lobe functions?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Cognitive functions in classic phenylketonuria and mild hyperphenylalaninaemia: experience in a paediatric population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Executive function in early-treated phenylketonuria: profile and underlying mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Psychiatric disorders in adult patients with early-treated phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Behaviour and school achievement in patients with early and continuously treated phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Psychiatric symptoms and disorders in phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Neurocognitive function in mild hyperphenylalaninemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

School performance in early and continuously treated phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Cognitive functions and the antioxidant system in phenylketonuric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Characterization of tremor in phenylketonuric patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Global and regional volume changes in the brains of patients with phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Twenty-five years of research on neurocognitive outcomes in early-treated phenylketonuria: intelligence and executive function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Neuropsychology of early-treated phenylketonuria: specific executive function deficits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Effect on intelligence of relaxing the low phenylalanine diet in phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Development of intelligence in early treated phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Comments on cognition and intelligence in phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

The natural history of untreated phenylketonuria over 20 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Mutational spectrum of phenylalanine hydroxylase deficiency in the population resident in Catalonia: genotype-phenotype correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Long-term beneficial effects of the phenylalanine-restricted diet in late-diagnosed individuals with phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Adult care in phenylketonuria and hyperphenylalaninaemia: the relevance of neurological abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

White matter pathology in phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Brain MRI changes in phenylketonuria. Associations with dietary status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Neurological outcome in adult patients with early-treated phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Behaviour in early treated phenylketonuria: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

ADHD, learning, and academic performance in phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Prevalence of stimulant use for attentional dysfunction in children with phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Intellectual and school performance in adolescents with phenylketonuria according to their dietary compliance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

Psychosocial aspects of PKU: hidden disabilities--a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.015

10.1016/J.YMGME.2011.07.015

7 January 2021

Identifiers

DOI

1 reference

25 August 2017

1 reference